Follow the 바이넥스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 바이넥스 has recorded 38 public disclosures. Market capitalisation: €228.3bn. The latest transaction was disclosed on 3 July 2026 (Other). Among the most active insiders: 더에이블. All data is accessible without an account.
38
Insider Decl.
0
Thresholds
·
6 ops.
Buy Volume
·
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 바이넥스 Strong Buy (bullish), based on 2 analysts. Average price target: ₩12,550.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,145 of 26,212 companies
19.7
score / 100
Value
17
Quality
22
FCF yld-20%
Earn yld-1.4%
EV/EBITDA25.7x
ROE·
Gross mgn27%
Net mgn-1.9%
Debt/EBITDA7.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
바이넥스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products.